PB2159: FREQUENCY OF PRACTICE-CHANGING FINDINGS IDENTIFIED BY COMPREHENSIVE GENOMIC PROFILING IN NON-MYELOID HEMATOLOGIC MALIGNANCIES

PB2159: FREQUENCY OF PRACTICE-CHANGING FINDINGS IDENTIFIED BY COMPREHENSIVE GENOMIC PROFILING IN NON-MYELOID HEMATOLOGIC MALIGNANCIES

Bibliographic Details
Main Authors:	C. Lin, K. Zhou, M. Green, B. Caughey, M. Datto, J. Strickler, M. McKinney
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000851464.77914.69

Similar Items

Myeloid hematological malignancies
by: D. A. Domninsky
Published: (2014-07-01)

Myeloid hematological malignancies
by: D. A. Domninsky
Published: (2014-07-01)

PB2159: CHARACTERIZATION OF THE IMMUNE RESPONSE DEVELOPED IN PATIENTS WITH MULTIPLE MYELOMA AFTER RECEIVING TWO DOSES OF THE VACCINE AGAINST SARS-COV-2
by: Laura Perez, et al.
Published: (2023-08-01)

Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies
by: Vaishali Bhardwaj, et al.
Published: (2023-04-01)

Functional Characterization of PknI-Rv2159c Interaction in Redox Homeostasis of Mycobacterium tuberculosis
by: Arunkumar Venkatesan, et al.
Published: (2016-10-01)

Incidence and Bayesian Mapping of Myeloid Hematologic Malignancies in Sardinia, Italy
by: Giorgio Broccia, et al.
Published: (2023-09-01)

Myeloid-derived suppressor cells in hematological malignancies: friends or foes
by: Meng Lv, et al.
Published: (2019-10-01)

Myeloid derived suppressor cells as therapeutic target in hematological malignancies
by: Kim eDe Veirman, et al.
Published: (2014-12-01)

PB1843: ACUTE MYELOID LEUKEMIA WITH PHILADELPHIA CHROMOSOME: EXPERIENCE OF SFAX HEMATOLOGY DEPARTMENT
by: N. Siala, et al.
Published: (2022-06-01)

PB2693: ANEMIA IN HEMATOLOGIC MALIGNANCIES: NOT ONLY A SYMPTOM.
by: Oumayma Hari, et al.
Published: (2023-08-01)

PROPTOSIS IN ACUTE MYELOID LEUKEMIA: AN UNDER RECOGNIZED PRESENTATION OF HEMATOLOGICAL MALIGNANCY
by: Tanzeela Farah, et al.
Published: (2021-12-01)

MALIGNANT HEMATOLOGIC FINDINGS BEYOND TYPICAL ENDOCRINE CONDITIONS
by: Adina Ghemigian, et al.
Published: (2017-03-01)

Frequency of hematologic and solid malignancies in the family history of 50 patients with acute myeloid leukemia - a single center analysis.
by: Anne-Sophie Sandner, et al.
Published: (2019-01-01)

PB2587: BLOODSTREAM INFECTIONS AMONG PATIENTS WITH HEMATOLOGICAL MALIGNANCY IN ARMENIA
by: Diana Soghomonyan, et al.
Published: (2023-08-01)

Comprehensive characterization of TGFB1 across hematological malignancies
by: Cui-zhu Wang, et al.
Published: (2023-11-01)

Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies
by: Saeed Daneshmandi, et al.
Published: (2024-03-01)

Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
by: Shunjie Yu, et al.
Published: (2022-07-01)

PB2358: SIGNIFICANT INCREASE IN NEWLY DIAGNOSED HEMATOLOGICAL MALIGNANCIES FOLLOWING LOCKDOWN EASE IN CROATIA
by: M. Simunic, et al.
Published: (2022-06-01)

Role of a Putative Alkylhydroperoxidase Rv2159c in the Oxidative Stress Response and Virulence of <i>Mycobacterium tuberculosis</i>
by: Gunapati Bhargavi, et al.
Published: (2022-06-01)

Corrigendum to: “Farnesoid X receptor (FXR): Structures and ligands” [Comput. Struct. Biotechnol. J. 19 (2021) 2148–2159]
by: Longying Jiang, et al.
Published: (2022-01-01)

PB1748: LOW HAIR CORTISOL CONCETRANTIONS AT DIAGNOSIS OF CHILDHOOHD HEMATOLOGICAL MALIGNANCIES
by: Panagiota Kourou, et al.
Published: (2023-08-01)

PB2700: ANXIETY AND DEPRESSION IN HEMATOLOGICAL MALIGNANCIES PATIENTS: FOCUS ON TREATMENT ADHERENCE
by: Dmitry E Vybornykh, et al.
Published: (2023-08-01)

PB2255: ANTIMICROBIAL SUSCEPTIBILITY TO MICROORGANISMS IN HEMATOLOGICAL MALIGNANCIES; A NEED TO REVIEW INSTITUTIONAL PROTOCOLS
by: N. ANWAR, et al.
Published: (2022-06-01)

Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies
by: Shifen Wang, et al.
Published: (2023-03-01)

PB2350: HEMATOLOGIC MALIGNANCIES AND AUTO-IMMUNITY: A CASE SERIES OF 21 PATIENTS
by: Hind Hanani, et al.
Published: (2023-08-01)

Checkpoint inhibition in hematologic malignancies
by: Aaron Tsumura, et al.
Published: (2023-10-01)

Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies
by: Verena Petzer, et al.
Published: (2022-03-01)

PB2200: CLONAL HEMATOPOIESIS AT THE CROSSROADS OF INFLAMMATORY BOWEL DISEASES AND HEMATOLOGICAL MALIGNANCIES: A BIOLOGICAL LINK?
by: C. Cumbo, et al.
Published: (2022-06-01)

Hematologic malignancies during preg
by: Hossam K. Mahmoud, et al.
Published: (2016-07-01)

Clinico-Pathological Findings in Myeloid Malignancies: A Single Center Experience
by: Faheem Ahmed Memon, et al.
Published: (2017-03-01)

Advances in malignant hematology /
by: Saba, Hussain I. 536043, et al.
Published: (2011)

Autophagy in Hematological Malignancies
by: Olga García Ruiz, et al.
Published: (2022-10-01)

Candidiasis in hematologic malignancies
by: V. B. Larionova, et al.
Published: (2022-11-01)

Lymphoid hematological malignancies
by: D. A. Domninskiy
Published: (2014-07-01)

Lymphoid hematological malignancies
by: D. A. Domninskiy
Published: (2014-07-01)

Carbamazepine and Hematological Malignancies
by: İrfan Yavaşoğlu, et al.
Published: (2013-12-01)

Eponyms in Malignant Hematology
by: Danielle Brazel, et al.
Published: (2022-01-01)

Neoantigens in Hematologic Malignancies
by: Melinda A. Biernacki, et al.
Published: (2020-02-01)

Deubiquitinases in hematological malignancies
by: Hu Lei, et al.
Published: (2021-08-01)

An Analysis of Transcriptomic Burden Identifies Biological Progression Roadmaps for Hematological Malignancies and Solid Tumors
by: Dashnamoorthy Ravi, et al.
Published: (2022-10-01)